These include loss of MHC expression, expression of immune-checkpoint proteins such as programmed cell death protein 1 (PD-1) and cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4), as well as the regulation of the local tumor microenvironment to produce an immunosuppressive biochemical milieu. The gene discussed is PDCD1; the disease is neoplasm.